Financial Metrics Unveiled: Xenetic Biosciences Inc (XBIO)’s Key Ratios in the Spotlight

Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Xenetic Biosciences Inc (NASDAQ: XBIO) closed at $4.20 in the last session, up 2.19% from day before closing price of $4.11. In other words, the price has increased by $2.19 from its previous closing price. On the day, 60749.0 shares were traded. XBIO stock price reached its highest trading level at $4.44 during the session, while it also had its lowest trading level at $4.1.

Ratios:

We take a closer look at XBIO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.96 and its Current Ratio is at 6.96. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on January 08, 2020, initiated with a Buy rating and assigned the stock a target price of $2.50.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XBIO now has a Market Capitalization of 6476987 and an Enterprise Value of -927758. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.57 while its Price-to-Book (P/B) ratio in mrq is 0.92. Its current Enterprise Value per Revenue stands at -0.368.

Stock Price History:

Over the past 52 weeks, XBIO has reached a high of $5.20, while it has fallen to a 52-week low of $2.78. The 50-Day Moving Average of the stock is 6.79%, while the 200-Day Moving Average is calculated to be 5.61%.

Shares Statistics:

According to the various share statistics, XBIO traded on average about 20.46K shares per day over the past 3-months and 28520 shares per day over the past 10 days. A total of 1.54M shares are outstanding, with a floating share count of 1.25M. Insiders hold about 18.67% of the company’s shares, while institutions hold 3.16% stake in the company. Shares short for XBIO as of 1730332800 were 14832 with a Short Ratio of 0.41, compared to 1727654400 on 3040. Therefore, it implies a Short% of Shares Outstanding of 14832 and a Short% of Float of 1.0199999.

Most Popular